If you cannot read this message, click here.
     DDNews Top 5 Cancer Stories
       April 2016
From our April 2016 issue:
By Jeffrey Bouley, DDNews Chief Editor
Roche and Blueprint Medicines collaborate to combine former's cancer immunotherapy expertise with latter's drug discovery platform and immunokinase expertise
 
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Senior Editor
The partners will conduct a pair of studies to assess the safety and tolerability of combining daratumumab with atezolizumab
 
From DDNews Online:
By Lloyd Dunlap, DDNews Managing Editor
Study to include study of onapristone in combination with abiraterone
 
From DDNews Daily News:
By Kelsey Kaustinen, DDNews Senior Editor
Kite, Genentech to test combination therapy in patients with refractory, aggressive non-Hodgkin lymphoma
 
From DDNews Daily News:
By Jeffrey Bouley, DDNews Chief Editor
This strong growth will occur in spite of patent expiries of very commercially successful products, including Avastin, Erbitux and Herceptin, says GBI Research
 
 
Facebook Facebook
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600 | Fax: 440-331-7563
©2016 Old River Publications LLC. All Rights Reserved.
Web site designed and managed by Offenberger & White, Inc..
Please note that this email was sent from an unmonitored address, so please do not reply directly to this email.
If you no longer wish to receive DDNews mailings, please unsubscribe here.